checkAd

BioLargo Q1 2022 Earnings Results Webcast and Conference Call on Thursday, May 19, 2022 - 4:00 PM Eastern Time

WESTMINSTER, CA / ACCESSWIRE / May 17, 2022 / BioLargo, Inc. (OTCQB:BLGO), a developer of cleantech technologies and full-service environmental engineering company, announced it will host an investor webcast and conference call on Thursday May 19, …

WESTMINSTER, CA / ACCESSWIRE / May 17, 2022 / BioLargo, Inc. (OTCQB:BLGO), a developer of cleantech technologies and full-service environmental engineering company, announced it will host an investor webcast and conference call on Thursday May 19, 2022, at 1:00 pm Pacific Time / 4:00 pm Eastern Time. The event, which will be open to the public, will be held to review the company's financial results for the three months ended March 31, 2022, discuss recent milestones and upcoming projects, and conduct a question-and-answer session.

To listen to a live broadcast, go to the site linked below at least 15 minutes prior to the scheduled start time to register and download any necessary audio video software.

To participate in the live webcast and teleconference:

Webcast Link:

https://www.webcaster4.com/Webcast/Page/2448/45648

Teleconference Domestic:

888-506-0062

Teleconference International:

Participant Access Code:

973-528-0011

784818

To watch or listen to a replay of the webcast or teleconference:

Webcast Replay Expiration:

Friday, May 19, 2023

Teleconference Replay Expiration:

Thursday, June 02, 2022

Teleconference Replay Domestic:

877-481-4010

Teleconference Replay International:

919-882-2331

Replay Passcode:

45648

The webcast replay and accompanying presentation materials will be made available on the Investor Relations section of BioLargo's website at www.biolargo.com/investor-relations.

About BioLargo, Inc.

BioLargo, Inc. (OTCQB:BLGO) invents, develops, and commercializes innovative technologies in the cleantech space, including for PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. With over 13 years of extensive R&D, BioLargo holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering. Our approach is to invent or acquire novel technologies and develop them to maturity through our operating subsidiaries. We have developed a number of key channel partnerships to support the reach of our products and services and maximize their commercial potential. With a keen emphasis on collaborations with academic, municipal, and commercial organizations and associations, BioLargo has proven itself with over 80 awarded grants and numerous pilot projects. We monetize through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation and/or the sale of the IP. See our website at www.BioLargo.com.

Seite 1 von 2


Wertpapier



0 Kommentare
Nachrichtenquelle: Accesswire
 |  101   |   |   

Schreibe Deinen Kommentar

Disclaimer

BioLargo Q1 2022 Earnings Results Webcast and Conference Call on Thursday, May 19, 2022 - 4:00 PM Eastern Time WESTMINSTER, CA / ACCESSWIRE / May 17, 2022 / BioLargo, Inc. (OTCQB:BLGO), a developer of cleantech technologies and full-service environmental engineering company, announced it will host an investor webcast and conference call on Thursday May 19, …

Nachrichten des Autors

Titel
Titel
Titel
Titel